SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form DEF 14A - Other definitive proxy statements:
SEC Accession No. 0001193125-17-128075
Filing Date
2017-04-19
Accepted
2017-04-19 08:16:57
Documents
8
Period of Report
2017-05-25
Effectiveness Date
2017-04-19

Document Format Files

Seq Description Document Type Size
1 DEF 14A d311723ddef14a.htm DEF 14A 767005
2 GRAPHIC g311723g10r71.jpg GRAPHIC 7138
3 GRAPHIC g311723g20s41.jpg GRAPHIC 9474
4 GRAPHIC g311723g26o54.jpg GRAPHIC 37403
5 GRAPHIC g311723g66k04.jpg GRAPHIC 13231
6 GRAPHIC g311723g67s39.jpg GRAPHIC 20248
7 GRAPHIC g311723g80w28.jpg GRAPHIC 20541
8 GRAPHIC g311723g87s41.jpg GRAPHIC 19027
  Complete submission text file 0001193125-17-128075.txt   938398
Mailing Address 784 MEMORIAL DRIVE CAMBRIDGE MA 02139
Business Address 784 MEMORIAL DRIVE CAMBRIDGE MA 02139 6174531000
INFINITY PHARMACEUTICALS, INC. (Filer) CIK: 0001113148 (see all company filings)

IRS No.: 330655706 | State of Incorp.: DE | Fiscal Year End: 1231
Type: DEF 14A | Act: 34 | File No.: 000-31141 | Film No.: 17768464
SIC: 2834 Pharmaceutical Preparations